The Effect of Particle Size on the Absorption of Cyclosporin A Nanosuspensions

References

• Jain S, Kambam S, Thanki K, Jain AK. Cyclosporine A loaded self-nanoemulsifying drug delivery system (SNEDDS): implication of a functional excipient based co-encapsulation strategy on oral bioavailability and nephrotoxicity. RSC Adv. 2015;5:49633–49642. doi:10.1039/c5ra04762e
   Web of Science ®Google Scholar
• Basaran E, Demirel M, Sirmagul B, Yazan Y. Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery. J Microencapsul. 2010;27:37–47. doi:10.3109/02652040902846883
   PubMed Web of Science ®Google Scholar
• Liu M, Zhong X, Yang Z. Chitosan functionalized nanocochleates for enhanced oral absorption of cyclosporine A. Sci Rep. 2017;7:41322. doi:10.1038/srep41322
   PubMed Web of Science ®Google Scholar
• Kesisoglou F, Panmai S, Wu Y. Nanosizing–oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev. 2007;59:631–644. doi:10.1016/j.addr.2007.05.003
   PubMed Web of Science ®Google Scholar
• Du B,Shen G, Wang D, Pang L, Chen Z, Liu Z. Development and characterization of glimepiride nanocrystal formulation and evaluation of its pharmacokinetic in rats. Drug Deliv. 2013;20:25–33. doi:10.3109/10717544.2012.742939
   PubMed Web of Science ®Google Scholar
• Muller RH, Gohla S, Keck CM. State of the art of nanocrystals–special features, production, nanotoxicology aspects and intracellular delivery. Eur J Pharm Biopharm. 2011;78:1–9. doi:10.1016/j.ejpb.2011.01.007
   PubMed Web of Science ®Google Scholar
• Kayaert P, Li B, Jimidar I, et al. Solution calorimetry as an alternative approach for dissolution testing of nanosuspensions. Eur J Pharm Biopharm. 2010;76:507–513. doi:10.1016/j.ejpb.2010.09.009
   PubMed Web of Science ®Google Scholar
• Lu Y, Qi J, Dong X, Zhao W, Wu W. The in vivo fate of nanocrystals. Drug Discov Today. 2017;22:744–750. doi:10.1016/j.drudis.2017.01.003
   PubMed Web of Science ®Google Scholar
• Di J, Gao X, Du Y, et al. Size, shape, charge and “stealthy” surface: carrier properties affect the drug circulation time in vivo. Asian J Pharm Sci. 2021;16:444–458. doi:10.1016/j.ajps.2020.07.005
   PubMed Web of Science ®Google Scholar
• Li Q, Liu CG, Yu Y. Separation of monodisperse alginate nanoparticles and effect of particle size on transport of vitamin E. Carbohydr Polym. 2015;124:274–279. doi:10.1016/j.carbpol.2015.02.007
   PubMed Web of Science ®Google Scholar
• Wang R, Wang X, Jia X, Wang H, Li J, Li J. Impacts of particle size on the cytotoxicity, cellular internalization, pharmacokinetics and biodistribution of betulinic acid nanosuspensions in combined chemotherapy. Int J Pharm. 2020;588:119799. doi:10.1016/j.ijpharm.2020.119799
   PubMed Web of Science ®Google Scholar
• Langston Suen WL, Chau Y. Size-dependent internalisation of folate-decorated nanoparticles via the pathways of clathrin and caveolae-mediated endocytosis in ARPE-19 cells. J Pharm Pharmacol. 2014;66:564–573. doi:10.1111/jphp.12134
   PubMed Web of Science ®Google Scholar
• Xie Y, Shi B, Xia F, et al. Epithelia transmembrane transport of orally administered ultrafine drug particles evidenced by environment sensitive fluorophores in cellular and animal studies. J Control Release. 2018;270:65–75. doi:10.1016/j.jconrel.2017.11.046
   PubMed Web of Science ®Google Scholar
• Rejman J, Zuhorn I, Hoekstra D, Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J. 2004;377:159–169. doi:10.1042/bj20031253
   PubMed Web of Science ®Google Scholar
• Bi C, Miao XQ, Chow SF, et al. Particle size effect of curcumin nanosuspensions on cytotoxicity, cellular internalization, in vivo pharmacokinetics and biodistribution. Nanomedicine. 2017;13:943–953. doi:10.1016/j.nano.2016.11.004
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhao J, Guan J, et al. Exploration of nanocrystal technology for the preparation of lovastatin immediate and sustained release tablets. J Drug Deliv Sci Technol. 2019;50:107–112. doi:10.1016/j.jddst.2019.01.018
   Web of Science ®Google Scholar
• Zhang X, Li LC, Mao S. Nanosuspensions of poorly water soluble drugs prepared by top-down technologies. Curr Pharm Des. 2014;20:388–407. doi:10.2174/13816128113199990401
   PubMed Web of Science ®Google Scholar
• Jacob S, Nair AB, Shah J. Emerging role of nanosuspensions in drug delivery systems. Biomater Res. 2020;24:3. doi:10.1186/s40824-020-0184-8
   PubMedGoogle Scholar
• Pawar VK, Singh Y, Meher JG, Gupta S, Chourasia MK. Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery. J Control Release. 2014;183:51–66. doi:10.1016/j.jconrel.2014.03.030
   PubMed Web of Science ®Google Scholar
• Romero GB, Arntjen A, Keck CM, Muller RH. Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability. Int J Pharm. 2016;498:217–224. doi:10.1016/j.ijpharm.2015.12.019
   PubMed Web of Science ®Google Scholar
• Xie YS, Ren XL, Pan GX, Gao XM, Liu CX. The assessment of absorption of periplocin in situ via intestinal perfusion of rats by HPLC. Biomed Chromatogr. 2008;22:196–201. doi:10.1002/bmc.914
   PubMed Web of Science ®Google Scholar
• Wang XY, Lian H, Lu X-Y, et al. [Intestinal absorption of phenolic acids in Rhus chinensis extracts by in situ single-pass perfusion model in rats]. Zhongguo Zhong Yao Za Zhi. 2019;44:2373–2378. doi:10.19540/j.cnki.cjcmm.20190318.502 Chinese.
   PubMedGoogle Scholar
• Hu J, Chen D, Jiang R, Tan Q, Zhu B, Zhang J. Improved absorption and in vivo kinetic characteristics of nanoemulsions containing evodiamine-phospholipid nanocomplex. Int J Nanomedicine. 2014;9:4411–4420. doi:10.2147/IJN.S59812
   PubMed Web of Science ®Google Scholar
• Du J, Zhou Y, Wang L, Wang Y. Effect of PEGylated chitosan as multifunctional stabilizer for deacetyl mycoepoxydience nanosuspension design and stability evaluation. Carbohydr Polym. 2016;153:471–481. doi:10.1016/j.carbpol.2016.08.002
   PubMed Web of Science ®Google Scholar
• Guada M, Lasa-Saracibar B, Lana H, Dios-Vieitez Mdel C, Blanco-Prieto MJ. Lipid nanoparticles enhance the absorption of cyclosporine A through the gastrointestinal barrier: in vitro and in vivo studies. Int J Pharm. 2016;500:154–161. doi:10.1016/j.ijpharm.2016.01.037
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). J Control Release. 2002;80:129–144. doi:10.1016/S0168-3659(02)00025-1
   PubMed Web of Science ®Google Scholar
• Stappaerts J, Brouwers J, Annaert P, Augustijns P. In situ perfusion in rodents to explore intestinal drug absorption: challenges and opportunities. Int J Pharm. 2015;478:665–681. doi:10.1016/j.ijpharm.2014.11.035
   PubMed Web of Science ®Google Scholar
• Chen G, Min X, Zhang Q, Zhang Z, Synthesis CG. Evaluation of PEG-PR for water flux correction in an in Situ Rat Perfusion Model. Molecules. 2020;25:5123. doi:10.3390/molecules25215123
   PubMed Web of Science ®Google Scholar
• Hussain N, Jaitley V, Florence AT. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev. 2001;50:107–142. doi:10.1016/S0169-409X(01)00152-1
   PubMed Web of Science ®Google Scholar
• Fricker G, Drewe J, Huwyler J, Gutmann H, Beglinger C. Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation. Br J Pharmacol. 2012;118:1841–1847. doi:10.1111/j.1476-5381.1996.tb15612.x
   Web of Science ®Google Scholar
• Fojo AT, Ueda KS, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A. 1987;84:265–269. doi:10.1073/pnas.84.1.265
   PubMed Web of Science ®Google Scholar
• Cao X, Gibbs ST, Fang L, et al. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharm Res. 2006;23:1675–1686. doi:10.1007/s11095-006-9041-2
   PubMed Web of Science ®Google Scholar
• Witoonsaridsilp W, Panyarachun B, Jaturanpinyo M, Sarisuta N. Phospholipid vesicle–bound lysozyme to enhance permeability in human intestinal cells. Pharm Dev Technol. 2013;18:821–827. doi:10.3109/10837450.2012.700930
   PubMed Web of Science ®Google Scholar
• Des Rieux A, Fievez V, Garinot M, Schneider YJ, Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release. 2006;116:1–27. doi:10.1016/j.jconrel.2006.08.013
   PubMed Web of Science ®Google Scholar
• Gao L, Liu G, Ma J, et al. Drug nanocrystals: in vivo performances. J Control Release. 2012;160:418–430. doi:10.1016/j.jconrel.2012.03.013
   PubMed Web of Science ®Google Scholar
• Kulkarni SA, Feng SS. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm Res. 2013;30:2512. doi:10.1007/s11095-012-0958-3
   PubMed Web of Science ®Google Scholar